Blood–brain barrier (BBB) is a natural protective membrane that prevents central nervous
system (CNS) from toxins and pathogens in blood. However, the presence of BBB …

Alzheimer's disease (AD) is a neurodegenerative disorder accounting for over 50% of all
dementia patients and representing a leading cause of death worldwide for the global …

Although nanomedicine have greatly developed and human life span has been extended,
we have witnessed the soared incidence of central nervous system (CNS) diseases …

Biomaterials have provided promising strategies towards improving the functions of injured
tissues of the nervous system. Recently, 2D nanomaterials, such as graphene, layered …

Viral diseases have long been among the biggest challenges for healthcare systems around
the world. The recent Coronavirus Disease 2019 (COVID-19) pandemic is an example of …

Abstract Two-dimensional (2D) nanomaterials, such as graphene, black phosphorus and
transition metal dichalcogenides, have attracted increasing attention in biology and …

Intranasal administration is becoming increasingly more attractive as a fast delivery route to
the brain for therapeutics circumventing the blood-brain barrier (BBB). Gold nanorods …

The interest in graphene-based nanomaterials (GBNs) application in nanomedicine, in
particular in neurology, steadily increased in the last decades. GBNs peculiar physical …

MXenes and graphene are two-dimensional materials that have gained increasing attention
in neuroscience, particularly in sensing, theranostics, and biomedical engineering. Various …

Alzheimer's disease (AD) is a common neurodegenerative disease that brings about
enormous economic pressure to families and society. Inhibiting abnormal aggregation of Aβ …